Abstract |
Although motor impairments in Parkinson's disease (PD) are attributed to nigrostriatal dopaminergic denervation, postural instability and gait difficulty (PIGD) features are less responsive to dopaminergic medications. PIGD features are a risk factor also for the development of dementia in PD (PDD). These observations suggest that nondopaminergic mechanisms may contribute to axial motor impairments. The aim was to perform a correlative PET study to examine the relationship between neocortical β- amyloid deposition ([(11)C]- Pittsburgh Compound B), nigrostriatal dopaminergic denervation ([(11)C]- dihydrotetrabenazine), and PIGD feature severity in PD patients at risk for dementia. This was a cross-sectional study of 44 PD patients (11 female and 33 male; 69.5 ± 6.6 years of age; 7.0 ± 4.8 years motor disease duration; mean H & Y stage: 2.7 ± 0.5) who underwent PET, motor feature severity assessment using the Movement Disorder Society revised UPDRS, and the Dementia Rating Scale (DRS). Linear regression (R(2)(adj) = 0.147; F(4,39) = 2.85; P = 0.036) showed that increased PIGD feature severity was associated with increased neocortical [(11)C]- Pittsburgh Compound B binding (β = 0.346; t(39) = 2.13; P = 0.039) while controlling for striatal [(11)C]- dihydrotetrabenazine binding, age, and DRS total score. Increased neocortical β- amyloid deposition, even at low-range levels, is associated with higher PIGD feature severity in PD patients at risk for dementia. This finding may explain why the PIGD motor phenotype is a risk factor for the development of PDD.
|
Authors | Martijn L T M Müller, Kirk A Frey, Myria Petrou, Vikas Kotagal, Robert A Koeppe, Roger L Albin, Nicolaas I Bohnen |
Journal | Movement disorders : official journal of the Movement Disorder Society
(Mov Disord)
Vol. 28
Issue 3
Pg. 296-301
(Mar 2013)
ISSN: 1531-8257 [Electronic] United States |
PMID | 23239424
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
|
Copyright | Copyright © 2012 Movement Disorders Society. |
Chemical References |
- 2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole
- Amyloid beta-Peptides
- Aniline Compounds
- Carbon Isotopes
- Thiazoles
- dihydrotetrabenazine
- Tetrabenazine
|
Topics |
- Aged
- Aged, 80 and over
- Amyloid beta-Peptides
(metabolism)
- Aniline Compounds
- Carbon Isotopes
(pharmacokinetics)
- Cross-Sectional Studies
- Dementia
(complications)
- Female
- Gait Disorders, Neurologic
(etiology)
- Humans
- Magnetic Resonance Imaging
- Male
- Middle Aged
- Parkinson Disease
(complications, diagnostic imaging, metabolism)
- Positron-Emission Tomography
- Postural Balance
(physiology)
- Psychiatric Status Rating Scales
- Sensation Disorders
(etiology)
- Severity of Illness Index
- Tetrabenazine
(analogs & derivatives)
- Thiazoles
|